Sunday, September 11, 16:30-17:30
Symposium for Organ Protection - Paths to the Future
Sunday, September 11, 16:30-17:30
Chronic Active AMR in Renal Transplant: A Closer Look at Pathophysiology, Diagnosis, and Emerging Therapies
Sunday, September 11, 16:30-17:30
Looking to the Future: Update on International Guidelines for the Management of BK DNAemia and Nephropathy in Kidney Transplant Recipients and Potential New Therapies on the Horizon
Sunday, September 11, 17:30-18:30
Innovative approaches for prevention and treatment of COVID-19 in high risk populations
Monday, September 12, 13:10-14:10
Revolutionizing Transplant Care: Optimizing dd-cfDNA and Molecular Diagnostics
Monday, September 12, 16:00-16:25
Donor Derived Cell-Free DNA (AlloSure and AlloSeq cfDNA) in Transplantation
Monday, September 12, 17:35-18:35
Combining Blood Gene Expression Biomarkers and dd-cfDNA
Tuesday, September 13, 13:15-14:15
Improving Organ Transplant Outcomes: A Multidimensional Perspective
Wednesday, September 14, 13:15-14:15
Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation
Wednesday, September 14, 11:40 a.m.-12 p.m.
How Do You Identify and Manage Refractory CMV In Solid Organ Transplant Recipients? An Interactive Case-Based Discussion.
